Literature DB >> 29288290

Complete remission of hypertension in a hemodialysis patient after adrenalectomy for primary aldosteronism and renal transplantation.

Daisuke Watanabe1, Satoshi Morimoto2, Noriyoshi Takano1, Shihori Kimura1, Yasufumi Seki1, Kanako Bokuda1, Midori Sasaki-Yatabe1, Junichi Yatabe1, Hiromi Onizuka3, Tomoko Yamamoto3, Takashi Ando1, Atsuhiro Ichihara1.   

Abstract

A 64-year-old man was admitted to our hospital for the hormonal evaluation of a right adrenal adenoma. He had been diagnosed with severe proteinuria and hypertension, and antihypertensive treatment was started at the age of 60. His renal function gradually declined, and hemodialysis was begun at the age of 64. Since his blood pressure was uncontrollable and resistant to antihypertensive treatment, an endocrinological examination was performed for an incidental right adrenal mass detected by computed tomography. The results of screening, including captopril challenge and an adrenocorticotropin stimulation test for primary aldosteronism, and adrenal venous sampling suggested excessive aldosterone secretion from the right adrenal gland. Adrenalectomy was performed; his blood pressure decreased and became well-controlled with a reduced antihypertensive regimen. Furthermore, he received renal transplantation which resulted in normalization of his serum potassium level, improvement of renal function and hormonal levels such as plasma renin activity and aldosterone concentration, and satisfactory blood pressure without any antihypertensive medications. This case is extremely important to demonstrate the effects of adrenalectomy for primary aldosteronism in a hemodialysis patient. It is possible that adrenalectomy may be a useful treatment for primary aldosteronism even in patients undergoing hemodialysis. Careful long-term follow-up of our case and investigations of the efficacy of adrenalectomy in similar cases are needed to address this issue.

Entities:  

Keywords:  Aldosterone; Blood pressure; End-stage renal disease; Renin; Surgery

Year:  2017        PMID: 29288290      PMCID: PMC5886930          DOI: 10.1007/s13730-017-0299-5

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  19 in total

1.  Primary hyperaldosteronism in a patient with end-stage renal disease.

Authors:  Amir Kazory; I David Weiner
Journal:  Nephrol Dial Transplant       Date:  2006-11-24       Impact factor: 5.992

2.  Prognosis of primary aldosteronism in Japan: results from a nationwide epidemiological study.

Authors:  Yoshihiro Miyake; Keiko Tanaka; Tetsuo Nishikawa; Mitsuhide Naruse; Ryoichi Takayanagi; Hironobu Sasano; Yoshiyu Takeda; Hirotaka Shibata; Masakatsu Sone; Fumitoshi Satoh; Masanobu Yamada; Hajime Ueshiba; Takuyuki Katabami; Yasumasa Iwasaki; Hirotoshi Tanaka; Yusuke Tanahashi; Shigeru Suzuki; Tomonobu Hasegawa; Noriyuki Katsumata; Toshihiro Tajima; Toshihiko Yanase
Journal:  Endocr J       Date:  2013-09-28       Impact factor: 2.349

3.  Involvement of aldosterone in left ventricular hypertrophy of patients with end-stage renal failure treated with hemodialysis.

Authors:  A Sato; J W Funder; T Saruta
Journal:  Am J Hypertens       Date:  1999-09       Impact factor: 2.689

4.  Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan.

Authors:  Masao Omura; Jun Saito; Kunio Yamaguchi; Yukio Kakuta; Tetsuo Nishikawa
Journal:  Hypertens Res       Date:  2004-03       Impact factor: 3.872

5.  Intrarenal hemodynamics in primary aldosteronism before and after treatment.

Authors:  Leonardo A Sechi; Alessandro Di Fabio; Massimo Bazzocchi; Alessandro Uzzau; Cristiana Catena
Journal:  J Clin Endocrinol Metab       Date:  2009-01-13       Impact factor: 5.958

Review 6.  Cardiovascular Risk in Primary Hyperaldosteronism.

Authors:  A Prejbisz; E Warchoł-Celińska; J W M Lenders; A Januszewicz
Journal:  Horm Metab Res       Date:  2015-11-17       Impact factor: 2.936

7.  The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.

Authors:  John W Funder; Robert M Carey; Franco Mantero; M Hassan Murad; Martin Reincke; Hirotaka Shibata; Michael Stowasser; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2016-03-02       Impact factor: 5.958

8.  A case of primary aldosteronism with chronic renal failure undergoing hemodialysis treatment.

Authors:  K Matsuda; K Shimamoto; N Ura; H Ogata; Y Shizukuda; M Iwakura; A Nozawa; K Kikuchi; O Iimura
Journal:  Endocrinol Jpn       Date:  1989-10

Review 9.  Vascular actions of aldosterone.

Authors:  Marie Briet; Ernesto L Schiffrin
Journal:  J Vasc Res       Date:  2012-11-21       Impact factor: 1.934

10.  Risk factors for maintenance hemodialysis patients undergoing elective and emergency abdominal surgery.

Authors:  Hayato Abe; Ken-ichi Mafune
Journal:  Surg Today       Date:  2014-01-21       Impact factor: 2.549

View more
  1 in total

1.  A Real Saline Challenge: Diagnosing Primary Aldosteronism in the Setting of Chronic Kidney Disease.

Authors:  Sasan Mirfakhraee; Maria Rodriguez; Niloofar Ganji; Richard J Auchus; Oksana Hamidi
Journal:  J Investig Med High Impact Case Rep       Date:  2021 Jan-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.